Efficacy of Serratus Anterior Plane Block With Dexmedetomidine During Breast Surgery
NCT ID: NCT05361837
Last Updated: 2024-05-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
172 participants
INTERVENTIONAL
2022-05-10
2024-08-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Safety of Dexmedetomidine Added to Modified Pectoral's Block in Breast Cancer Patients
NCT03046238
Serratus Anterior Plane Block Versus Paravertebral Block for Postmastectomy Analgesia
NCT02103946
Efficacy and Safety of Dexmedetomidine Added to Modified Pectoral's Block
NCT03063073
Dexamethasone Versus Dexmedetomidine as Adjuncts to Serratus Anterior Plane Block
NCT06300099
Efficacy of Serratus Anterior Plane Block Mastectomy
NCT03944759
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Single level serratus anterior plane block
the allocated patients will receive single injection serratus anterior plane block at the level of third rib with local anesthetics only
Single level serratus anterior plane block
Serratus anterior plane block with local anesthetics at the third rib
Single level serratus anterior plane block with dexmedetomidine
the allocated patients will receive single injection serratus anterior plane block at the level of third rib with local anesthetics and dexmedetomidine
Single level serratus anterior plane block with dexmedetomidine
Serratus anterior plane block with local anesthetics and dexmedetomidine at the third rib
Bilevel serratus anterior plane block
the allocated patients will receive injection serratus anterior plane block at 2 levels, the level of third rib and the level of the fifth rib with local anesthetics only
Bilevel serratus anterior plane block
Serratus anterior plane block with local anesthetics at the third and fifth rib
Bilevel serratus anterior plane block with dexmedetomidine
the allocated patients will receive injection serratus anterior plane block at 2 levels, the level of third rib and the level of the fifth rib with local anesthetics and dexmedetomidine
Bilevel serratus anterior plane block with dexmedetomidine
Serratus anterior plane block with local anesthetics and dexmedetomidine at the third and fifth rib
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Single level serratus anterior plane block
Serratus anterior plane block with local anesthetics at the third rib
Single level serratus anterior plane block with dexmedetomidine
Serratus anterior plane block with local anesthetics and dexmedetomidine at the third rib
Bilevel serratus anterior plane block
Serratus anterior plane block with local anesthetics at the third and fifth rib
Bilevel serratus anterior plane block with dexmedetomidine
Serratus anterior plane block with local anesthetics and dexmedetomidine at the third and fifth rib
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18-65 years,
* ASA I-II
Exclusion Criteria
* coagulation defects,
* abnormal kidney or liver functions,
* local infection at site of injection.
18 Years
65 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute, Egypt
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Walaa Youssef Elsabeeny
Assistant professor of Anesthesia and Pain management
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Walaa Y Elsabeeny, MD
Role: PRINCIPAL_INVESTIGATOR
Assistant Professor of Anesthesia and Pain management
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Walaa Y Elsabeeny
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AP2204-50104
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.